Clinical outcomes for patients with pancreatic adenocarcinoma (PAC) remain dismal. Radiation therapy has historically been a central component in the treatment of pancreatic adenocarcinoma; however, the role of radiation therapy has been called into question based on conflicting results. In this article, William A. Hall and Karyn A. Goodman present an overview of the rationale for radiation therapy in pancreatic adenocarcinoma and a summary of emerging clinical data and future directions to improve outcomes in this devastating malignancy.
Featured Review: Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy
Aims and scope
Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology.
The field of radiation oncology covers the integration of radiation therapy into multimodal treatment approaches. Radiation Oncology provides an open access forum for researchers and clinicians involved in the management and treatment of cancer patients, bringing together the latest research and advances in the field. Advances in treatment technology, as well as improved understanding of the underlying biological resistance mechanisms, will further strengthen the role of radiation oncology.
The editorial team of Radiation Oncology would like to thank all of our reviewers who have contributed to the journal.
A peer-reviewed journal would not survive without the generous time and insightful comments of the reviewers, whose efforts often go unrecognized. Although final decisions are always editorial, they are greatly facilitated by the deeper technical knowledge, scientific insights, understanding of social consequences, and passion that reviewers bring to our deliberations.
What is trending?
Click here to see which articles published in Radiation Oncology have been shared the most in the past three months.
Research Data Support
Authors submitting to this journal can opt to use a new service that will make it easier to share research data.
Prof Claus Belka, Ludwig Maximilian University of Munich, Germany
Please click here to read the Editor's Profile.
Annual Journal Metrics
69 days to first decision for reviewed manuscripts only
53 days to first decision for all manuscripts
128 days from submission to acceptance
15 days from acceptance to publication
470 Altmetric mentions